• Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Given Average Recommendation of "Buy" by Analysts

    来源: Buzz FX / 10 1月 2025 02:36:14   America/Chicago


    Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat January 10, 2025 Share Link copied to clipboard. Y-mAbs Therapeutics, Inc. ( NASDAQ:YMAB - Get Free Report ) has earned a consen
    Read more...
分享